Bullseye Asset Management LLC Neogenomics Inc Transaction History

Bullseye Asset Management LLC

$213 Million
Q4 2024

A detailed history of Bullseye Asset Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Bullseye Asset Management LLC holds 161,860 shares of NEO stock, worth $1.8 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

161,860

Previous 163,792 1.18%

Holding current value

$1.8 Million

Previous $2.42 Million 10.39%

% of portfolio

1.25%

Previous 1.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $25,116 - $35,606	-1,932 Reduced 1.18%	161,860 $2.67 Million
Q3 2023 Nov 15, 2023	BUY	$12.15 - $17.85 $325,850 - $478,719	26,819 Added 19.58%	163,792 $2.02 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $281,571 - $602,483	30,976 Added 29.22%	136,973 $2.39 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $17,881 - $29,370	-2,275 Reduced 2.1%	105,997 $913,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $1,539 - $3,045	218 Added 0.2%	108,272 $883,000
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $25,745 - $32,457	-618 Reduced 0.57%	108,054 $5.21 Million
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $57,475 - $89,956	-1,593 Reduced 1.44%	108,672 $5.85 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $3,991 - $4,857	-120 Reduced 0.11%	110,265 $4.07 Million
Q2 2020 Aug 11, 2020	BUY	$24.21 - $31.02 $580,434 - $743,704	23,975 Added 27.75%	110,385 $3.42 Million
Q1 2020 May 08, 2020	SELL	$20.5 - $34.53 $1.08 Million - $1.81 Million	-52,445 Reduced 37.77%	86,410 $2.39 Million
Q4 2019 Feb 18, 2020	BUY	$18.96 - $29.84 $2.63 Million - $4.14 Million	138,855 New	138,855 $4.06 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.

Account

Bullseye Asset Management LLC Neogenomics Inc Transaction History